Telstra Group Ltd (ASX: TLS) shares may be one of the most popular dividend options due to the company’s perceived stability and dividend yield.

The ASX telco share usually has a higher dividend yield than the ASX bank shares of Commonwealth Bank of Australia (ASX: CBA) and Macquarie Group Ltd (ASX: MQG), though typically lower than names like Westpac Banking Corp (ASX: WBC), National Australia Bank Ltd (ASX: NAB) and ANZ Group Holdings Ltd (ASX: ANZ).

Telstra has consistently increased its annual payout since the onset of the inflationary period in FY22.

Plus, the FY26 half-year result was yet another example of the bank providing investors with stability and growth – it hiked its interim dividend by 10.5% to 10.5 cents per share.

The HY26 result also showed the business is capable of growing earnings. It reported total income of 0.2% to $11.8 billion, operating profit (EBITDA) rose 4.7% to $4.4 billion, net profit for Telstra shareholders increased 9.4% and earnings per share (EPS) climbed 11.2%.

The cash profit was particularly good. Cash operating profit (EBIT) rose 14%, cash earnings grew 17%, and cash EPS increased 19.7%.

In this article, we’re going to look at the annual FY27 dividend, which will be paid in 2027.

2027 dividend projection for owners of Telstra shares

According to the projection on CMC Invest, the ASX telco share is projected to pay an annual dividend per share of 22 cents in the 2027 financial year.

At the time of writing, this forecast translates into a dividend yield of 4.4% excluding franking credits and a grossed-up dividend yield of approximately 6.1%, including franking credits.

If someone were to invest $8,000 in Telstra, they would be able to buy 1,603 Telstra shares (with a little bit of money left over).

With those 1,603 Telstra shares, investors could receive $352.66 of cash and approximately $136.03 franking credits.

Is this a good time to invest in the ASX telco share?

According to CMC Invest, there have been six analyst ratings calls on the business in the last three months.

Of those six, one was a buy rating and five were hold ratings. So, the investment professionals are largely neutral on the appeal of the company’s valuation right now.

The average price target of those six ratings is $5.33. That means, collectively, those analysts are predicting the Telstra share price could climb by around 7% within the next year (at the time of writing).

The Telstra share price was above $5.33 earlier this year, though it has clearly dropped back since then.

Telstra looks like a solid option for dividends, though there seem to be more compelling ASX shares out there to buy.

The post If I invest $8,000 in Telstra shares, how much passive income will I receive in 2027? appeared first on The Motley Fool Australia.

More reading

• How much do I need in superannuation to receive $5,500 per month in passive income?
• How to get started with a portfolio delivering $500 a week in passive income
• How much passive income can I earn off a $100,000 portfolio?
• Should I invest $5,000 in Telstra shares in July?
• These ASX shares could generate $5,000 per year in passive income

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Australia’s property market has been the defining economic story of 2026.

Three RBA rate hikes since January have pushed the official cash rate to 4.35%, the highest level since 2011.

The impact on house prices is now showing up in the data. 

CBA’s own economists forecast that dwelling price growth will slow to just 3% by December 2026, down from a prior forecast of 5%. 

What’s more, the Federal Budget’s negative gearing changes add a further headwind for established property prices.

For three of the most widely held ASX shares with direct property exposure, the implications are significant.

REA Group Ltd (ASX: REA): The listing volume threat

Rea Group is the most directly exposed of the three to the property price cycle. This is because its revenue depends on the volume and value of properties listed for sale rather than on owning property itself. 

REA Group shares have fallen 25% so far in 2026, as a combination of a softening property market and a Bell Potter downgrade to sell, with a $137 target, dented the stock’s long-held premium.

The concern is straightforward: if falling prices reduce vendor confidence, fewer Australians choose to list their properties for sale, and REA’s listing volume and yield per listing both come under pressure simultaneously.

That double headwind is precisely what Bell Potter flagged, noting that REA “currently trades around 28x FY27 P/E, which is a level it has historically only traded at during EPS declines.”

The counterargument is equally straightforward: falling prices can extend the time a property sits on the market before selling, which actually increases the total listing revenue REA generates per transaction.

Whether that offset is enough to compensate for lower volumes is the core debate about REA’s FY27 earnings.

Stockland Corporation Ltd (ASX: SGP): New builds vs established markets

Stockland Corporation is one of Australia’s largest residential developers.

The company develops new residential communities rather than selling existing ones. This has meant that the Federal Budget’s negative gearing exemption for new builds directly benefits the company by channelling investor demand away from established properties and toward the new homes Stockland sells. 

Stockland shares have fallen 31% in 2026, dragged lower by interest rate fears alongside the broader real estate sector rather than by any deterioration in the company’s operational performance.

The operational picture actually tells a different story.

In Q3 FY26, Stockland reported a 43% year-on-year lift in Masterplanned Communities sales and a 162% surge in Land Lease Community sales. These results were driven by the same housing shortage that policy changes are trying to address.  

Seven of 10 analysts covering Stockland have a buy or strong buy rating, reflecting confidence in the stock’s future prospects.

Mirvac Group (ASX: MGR): A new-build tailwind hiding inside a falling market

Mirvac Group shares the same structural advantage as Stockland, developing new residential properties rather than trading established ones. 

The Federal Budget’s decision to preserve the negative gearing concession for new builds while restricting it for established properties creates a direct demand incentive for investors to buy new Mirvac apartments and townhouses rather than established properties.

In Q3 FY26, Mirvac delivered a 28% year-on-year lift in residential sales, with management reaffirming full-year guidance. Furthermore, management confirmed the new-build demand tailwind is translating into real sales momentum. 

Mirvac shares have fallen approximately 25% over the past twelve months as the rate-hiking cycle weighed on REIT valuations across the sector. 

Despite this, Macquarie carries an outperform rating on Mirvac with a price target of $2.70. The broker has argued that the residential recovery and build-to-rent growth story can drive earnings higher even in a higher-for-longer rate environment. 

The common thread for ASX property stocks

Falling house prices are not uniformly bad news for every ASX company with property exposure.

REA Group faces the most direct headwind, with its listing revenue model exposed to both lower volumes and reduced vendor confidence. 

Stockland and Mirvac, as new residential developers, are paradoxically better positioned than their share price declines suggest. These companies benefit from the very policy changes driving established property prices lower.

For investors, understanding which side of that distinction each company sits on is the most important question heading into FY27. 

Foolish Takeaway

Property prices are falling in Australia’s two largest cities, and the impact on ASX property shares is material.

REA Group faces the clearest earnings headwind as listing volumes soften.

Stockland and Mirvac, counterintuitively, may be among the few property-exposed ASX shares that benefit from today’s policy environment. 

The post Property prices are falling. Here are the ASX shares most affected appeared first on The Motley Fool Australia.

More reading

• 6 ASX shares upgraded by experts this week
• Should you buy property or stocks? Here’s what you need to consider
• How to get started with a portfolio delivering $500 a week in passive income
• How much passive income can I earn off a $100,000 portfolio?
• How much do I need in my superannuation to get $1500 per week in passive income?

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The team at Morgans has been running the rule over a number of popular ASX shares again this week.

Let’s see if it rates these as buys, holds, or sells. Here’s what you need to know:

Objective Corporation Ltd (ASX: OCL)

Morgans remains positive on this software provider despite the loss of a major government contract.

It notes that the company’s shares have been hammered and are now at a five-year low. In response, the broker has retained its buy rating on Objective Corp’s shares with a reduced price target of $11.50. It commented:

OCL’s largest and longest standing customer, the Australian Department of Defence, has elected not to renew its Upgrade and Support (USP) agreement for Objective ECM, a relationship that has been in place for over 25 years. Whilst OCL expects no impacts to earnings in FY26, the group has flagged that the impact from the loss in revenue will see FY26 ARR end the period “in line with FY25” on a constant currency basis (i.e. ~A$120m Pre FY26 FX headwinds). Rebasing our forecasts for OCL’s revised FY26 ARR, our NPAT estimates reduce by ~22-23% in FY27-28F. Whilst this is a disappointing and unexpected update, post our revisions OCL is trading on FY27F P/E of 21x, with a share price at 5-years lows. We therefore reiterate our Buy rating with a revised PT of $11.50/sh.

ResMed Inc (ASX: RMD)

Morgans also highlights that ResMed shares have de-rated materially this year. This is despite the market continuing to expect strong earnings growth from the sleep disorder treatment company. 

While there are risks, Morgans remains bullish and has put a buy rating and $41.72 price target on its shares. It said:

RMD has de-rated to ~16x forward earnings, its lowest valuation since the post-GFC period, despite consensus continuing to forecast double-digit EPS growth. GLP-1 therapies, positive Phase III data from Apnimed’s oral OSA therapy, the prospect of Philips re-entering the US PAP market from 2027 and broader healthcare sector de-rating, have driven recent share price weakness. While these risks are real, current industry data and RMD’s operating performance provide limited evidence of a material deterioration in underlying demand. We make no changes to FY26-28 forecasts or our A$41.72 target price. BUY.

South32 Ltd (ASX: S32)

Finally, this mining giant has been downgraded by Morgans following news that it is selling its aluminium business for US$5.6 billion. 

The broker has cut its recommendation to hold with a trimmed price target of $4.50. It explains:

S32 has agreed to sell its entire ali business for total consideration of US$5.6bn (US$4.1bn upfront), and transfer of US$1.2bn closure/rehab liabilities. Our view on S32’s aluminium sale is genuinely mixed. It leaves S32 a simpler and, in important respects, a better business, but also a smaller and less valuable one. Total value of up to ~US$6.8bn, which sits at a discount to consensus/Morgans valuations of US$8.8-9.2bn. We reduce our valuation on S32’s ali assets to in line with the agreed Alcoa deal, and shift our valuation methodology to a blended NAV:EBITDA valuation of A$4.50 (from A$5.00). As a result we update our rating to HOLD (from Accumulate).

The post Buy, hold, sell: Objective Corp, ResMed, and South32 shares appeared first on The Motley Fool Australia.

More reading

• 9 ASX 200 shares with renewed buy ratings for FY27
• 10 of the best ASX shares to buy in FY 2027
• 7 ASX shares downgraded by brokers this week
• Top 3 ASX healthcare stocks to buy today
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Objective and ResMed. The Motley Fool Australia has positions in and has recommended Objective and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.